SILO Earnings

Quarterly EPS
$-0.22
Q3 2024
$-0.38
Q4 2024
$-0.23
Q1 2025
$-2.88
Q2 2025
$-0.12
Q3 2025
$-0.05
Q4 2025
$-0.12
Q1 2026
$-0.76
Q2 2026
Latest RevenueN/A
Latest Net Income-832829
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.760-832829-100.0%+73.6%
Q1 2026-$0.1218.0K-1647117+0.0%+47.8%
Q4 2025-$0.0518.0K-881530+0.0%+86.8%
Q3 2025-$0.1218.0K-1110438+0.0%+45.5%
Q2 2025-$2.8818.0K-1204293+0.0%-829.0%
Q1 2025-$0.2318.0K-1031437+0.0%+17.9%
Q4 2024-$0.3818.0K-1730620+0.0%+2.6%
Q3 2024-$0.2218.0K-928814+0.0%-4.8%
Q2 2024-$0.3118.0K-931779
Q1 2024-$0.2818.0K-801667
Q4 2023-$0.3918.0K-1121176
Q3 2023-$0.2118.0K-660160
Silo Pharma (SILO) — Earnings